Results 81 to 90 of about 92,715 (204)

EBOLA

Zdravniški Vestnik, 2014
The ongoing outbreak of Ebola virus disease is by far the largest in  the history of Ebola virus since its initial description in 1976. Apart from dramatic increase of detected cases in the current outbreak of Ebola virus disease in West Africa, there ...
Tadeja Kotar
doaj  

Infection Risk From Humans and Animals in the Anatomy Laboratory: A Scoping Review

Clinical Anatomy, Volume 39, Issue 3, Page 346-367, April 2026.
ABSTRACT Whole‐body dissection is a cornerstone of anatomy education. During and following the COVID‐19 pandemic, exposure to infectious agents and other risks of dissection were highlighted. To identify potential risks, one must have the data outlining these risks in specific situations.
Margaret A. McNulty, Elizabeth R. Agosto
wiley   +1 more source

Rapid Decision Algorithm for Patient Triage during Ebola Outbreaks

Emerging Infectious Diseases
The low specificity of Ebola virus disease clinical signs increases the risk for nosocomial transmission to patients and healthcare workers during outbreaks.
Denis-Luc Ardiet, Justus Nsio, Gaston Komanda, Rebecca M. Coulborn, Emmanuel Grellety, Francesco Grandesso, Richard Kitenge, Dolla L. Ngwanga, Bibiche Matady, Guyguy Manangama, Mathias Mossoko, John K. Ngwama, Placide Mbala, Francisco Luquero, Klaudia Porten, Steve Ahuka-Mundeke   +15 more
doaj   +1 more source

Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro

Molecular Therapy: Nucleic Acids, 2019
Ebola virus is the causative agent of Ebola virus disease, a severe, often fatal illness in humans. So far, there are no US Food and Drug Administration (FDA)-approved therapeutics directed against Ebola virus.
Anne Sadewasser, Erik Dietzel, Sven Michel, Michael Klüver, Markus Helfer, Tamara Thelemann, Richard Klar, Markus Eickmann, Stephan Becker, Frank Jaschinski   +9 more
doaj   +1 more source

Virus-encoded miRNAs in Ebola virus disease [PDF]

Scientific Reports, 2018
AbstractEbola virus (EBOV) is a negative-strand RNA virus that replicates in the cytoplasm and causes an often-fatal hemorrhagic fever. EBOV, like other viruses, can reportedly encode its own microRNAs (miRNAs) to subvert host immune defenses. miRNAs are short noncoding RNAs that can regulate gene expression by hybridizing to multiple mRNAs, and viral ...
Janice Duy, Anna N. Honko, Louis A. Altamura, Sandra L. Bixler, Suzanne Wollen-Roberts, Nadia Wauquier, Aileen O’Hearn, Eric M. Mucker, Joshua C. Johnson, Joshua D. Shamblin, Justine Zelko, Miriam A. Botto, James Bangura, Moinya Coomber, M. Louise Pitt, Jean-Paul Gonzalez, Randal J. Schoepp, Arthur J. Goff, Timothy D. Minogue   +18 more
openaire   +3 more sources

Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir

British Journal of Pharmacology, Volume 183, Issue 7, Page 1578-1601, April 2026.
Background and Purpose Human adenovirus (HAdV) causes respiratory or gastrointestinal tract infections depending on the virus subtype. While HAdV infections are generally self‐limiting in immunocompetent people, they can result in significant morbidity and mortality in immunocompromised adults and children.
Mohamed Zamzamy, Sophie Post, Wing Hang Ip, Elin Hahlin, Sebastian Kühn, Andrea Pirosu, Christian Conze, Martin Baumdick, Hamburg Intestinal Study Group, Madeleine J. Bunders, Britta F. Zecher, Angelique Hoelzemer, Stephan Linder, Niklas Arnberg, Thomas Dobner, Marcus Altfeld, Sebastian Schloer   +16 more
wiley   +1 more source

The risk of transmission of a viral haemorrhagic fever infection in a United Kingdom laboratory [PDF]

, 2017
No abstract ...
Shorten, Robert J., Wilson-Davies, Eleri
core   +2 more sources

Exploring the Impact of COVID‐19 on Acute Care Nurses: An Integrative Review

Journal of Advanced Nursing, Volume 82, Issue 4, Page 2685-2695, April 2026.
ABSTRACT Aim To analyse, critique, and synthesise available research to create a unique framework of the impacts of COVID‐19 on acute care nurses. Methods Whittemore and Knafl's framework was used to organise this review. The Mixed Methods Appraisal Tool was used for quality analysis.
Janelle Schentag, Kelly Penz, Helen Vandenberg   +2 more
wiley   +1 more source

IN VITRO DIAGNOSIS FOR EBOLA VIRUS DISEASE. A COMPARISON OF CURRENT TECHNIQUES AND DIAGNOSTIC ASSAYS

Журнал микробиологии, эпидемиологии и иммунобиологии, 2019
Ebola virus disease is dangerous viral infection, occurring in the form of hemorrhagic fever, characterized by acute clinical symptoms and high mortality rate due to multiple organ failure.
A. O. Sementsova, V. G. Dedkov, V. A. Ternovoy, E. V. Chub, S. A. Pyankov, A. P. Agafonov, R. A. Maksyutov, V. V. Maleev, A. Yu. Popova   +8 more
doaj   +1 more source

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization. [PDF]

, 2017
BACKGROUND: The recent West African Ebola epidemic led to accelerated efforts to test Ebola vaccine candidates. As part of the World Health Organisation-led VSV Ebola Consortium (VEBCON), we performed a phase I clinical trial investigating rVSV-ZEBOV (a ...
Addo, MM, Becker, S, Biedenkopf, N, Borregaard, S, Dahlke, C, Eickmann, M, Fehling, SK, Jambrecina, A, Kasonta, R, Krähling, V, Lohse, AW, Lunemann, S, Ly, ML, Lütgehetmann, M, Olearo, F, Rechtien, A, Schmiedel, S, Spohn, M, Stahl, F, Strecker, T, Stubbe, HC, VEBCON Consortium, Zinser, ME   +22 more
core   +1 more source